Amin Hallihan
General
Cases25
Challenger50%
Patent Owner50%
NPE50%
--
--
Practice Areas
BiotechChemicalTransport., E-Comm.
Top Attorneys
Elite Ratings
DCTPTABCAFC
Analytics
Lawyers
Cases
Ratings Trends
Practice Areas
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 09/06/23 | SO ORDERED Granting (D.I. 143 in 18-cv-404-RGA-SRF; D.I. 261 in 17-cv-392-RGA) Unopposed Motion for Extension of Time to Comply with Protective Order Deadlines. Signed by Judge Richard G. Andrews on 9/6/2023. Associated Cases: 1:17-cv-00392-RGA, 1:18-cv-00404-RGA-SRF(nms) (Entered: 09/06/2023) | |
| 09/01/23 | Unopposed Motion for Extension of Time to Protective Order Deadlines - filed by Purdue Pharma L.P., Purdue Pharmaceuticals L.P., Rhodes Technologies, Grünenthal GmbH. (Dellinger, Megan) Modified on 9/5/2023 (nms). (Entered: 09/01/2023) | |
| 10/31/22 | USCA Order Terminating Appeal as to 410 Notice of Appeal (Federal Circuit) filed by Biogen International GmbH, Biogen MA Inc.. USCA Decision: Appeal Dismissed. (mdb) (Entered: 10/31/2022) | |
| 10/13/21 | MANDATE of USCA as to 742 Notice of Appeal (Federal Circuit) filed by Unichem Laboratories, Ltd., 740 Notice of Appeal (Federal Circuit) filed by Sigmapharm Laboratories LLC, 743 Notice of Appeal (Federal Circuit) filed by HEC Pharm USA Inc., Sunshine Lake Pharma Co. Ltd. (ntl) (Entered: 10/13/2021) | |
| 01/28/19 | USCA Order Terminating Appeal as to 509 Notice of Cross Appeal filed by Cephalon Inc., 508 Notice of Appeal (Federal Circuit) filed by InnoPharma Inc.. USCA Decision: appeals are voluntarily dismissed. (mdb) (Entered: 01/28/2019) | |
| 01/15/19 | MANDATE of USCA as to 228 Notice of Appeal (Federal Circuit) filed by Ezra Ventures LLC. (ntl) (Entered: 01/15/2019) |